Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-29T02:32:43.023Z Has data issue: false hasContentIssue false

Ultrastructure of Human Pancreatic Cancer Cells Treated with a TBK1 Inhibitor

Published online by Cambridge University Press:  05 August 2019

Linda Yasui*
Affiliation:
Northern Illinois University, Department of Biological Sciences, DeKalb, IL, USA.
Nicole Baker
Affiliation:
University of North Carolina, Department of Pharmacy, Chapel Hill, NC, USA.
Hannah Savage
Affiliation:
Northern Illinois University, Department of Biological Sciences, DeKalb, IL, USA.
Channing Der
Affiliation:
University of North Carolina, Department of Pharmacy, Chapel Hill, NC, USA.
*
*Corresponding author: lyasui@niu.edu

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Pharmaceuticals FIG – Imaging, Analysis, and Regulation of Medical Products, Devices and Data Integrity
Copyright
Copyright © Microscopy Society of America 2019 

References

[1]Barbie, DA et al. , Nature 462 (2009), p. 108.Google Scholar
[2]Cruz, VH and Brekken, RA. Journal of Cell Communication and Signaling 12 (2008), p. 83.Google Scholar
[3]Gentry, LR et al. , Biochimica Biophysica Acta 1843 (2014), p. 2976.Google Scholar
[4]Van Horn, R et al. , Molecular Cancer Therapy 12 (2013) abstract B229.Google Scholar
[5]Yasui, LS and Owens, K, International Journal of Radiation Biology 88 (2012), p. 980.Google Scholar
[6]Kern, E in “The Pancreas: Biology, Pathobiology, and Disease”, (Raven Press, Ltd., New York).Google Scholar